Cargando…
Molecular Alterations in Pancreatic Cancer: Transfer to the Clinic
Pancreatic ductal adenocarcinoma (PDA) is the most common cancer of the exocrine pancreas and probably the tumor that has benefited the least from clinical progress in the last three decades. A consensus has been reached regarding the histologic classification of the ductal preneoplastic lesions (pa...
Autores principales: | Rodríguez Gil, Yolanda, Jiménez Sánchez, Paula, Muñoz Velasco, Raúl, García García, Ana, Sánchez-Arévalo Lobo, Víctor Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923218/ https://www.ncbi.nlm.nih.gov/pubmed/33669845 http://dx.doi.org/10.3390/ijms22042077 |
Ejemplares similares
-
Targeting BPTF Sensitizes Pancreatic Ductal Adenocarcinoma to Chemotherapy by Repressing ABC-Transporters and Impairing Multidrug Resistance (MDR)
por: Muñoz Velasco, Raúl, et al.
Publicado: (2022) -
Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential
por: Alors-Pérez, Emilia, et al.
Publicado: (2023) -
pTERT C250T mutation: A potential biomarker of poor prognosis in metastatic melanoma
por: Blanco-García, Leyla, et al.
Publicado: (2023) -
Molecular alterations associated with prostate cancer
por: Garcia Perdomo, Herney Andres, et al.
Publicado: (2018) -
Molecular alterations in pancreatic tumors
por: Visani, Michela, et al.
Publicado: (2021)